Demography and intercontinental spread of the USA300 community-acquired methicillin-resistant Staphylococcus aureus lineage

mBio

Volumn 7, Issue 1, 2016, Pages

  Glaser, Philippe ^a,i   Martins Simões, Patrícia ^b,c,d,e   Villain, Adrien ^a   Barbier, Maxime ^f,g   Tristan, Anne ^b,c,d,e   Bouchier, Christiane ^a   Ma, Laurence ^a   Bes, Michele ^b,c,d,e   Laurent, Frederic ^b,c,d,e   Guillemot, Didier ^h   Wirth, Thierry ^f,g   Vandenesch, François ^b,c,d,e  

^a INSTITUT PASTEUR   (France)

^b CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE LYON   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f PSL RESEARCH UNIVERSITY   (France)

^g Sorbonne Universités   (France)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

ⁱ CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; MACROLIDE; MIKAMYCIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DEMOGRAPHY; FRANCE; GENE SEQUENCE; LIFE CYCLE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COMMUNITY; MOLECULAR CLONING; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; ADULT; BACTERIAL GENOME; CHILD; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; DNA SEQUENCE; EUROPE; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NORTH AMERICA; PHYLOGEOGRAPHY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSMISSION;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DEMOGRAPHY; DNA, BACTERIAL; EUROPE; EXOTOXINS; FRANCE; GENOME, BACTERIAL; HUMANS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NORTH AMERICA; PHYLOGENY; PHYLOGEOGRAPHY; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES; VIRULENCE FACTORS;

EID: 84960193204     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02183-15     Document Type: Article

References (91)

1. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339: 520–532. http://dx.doi.org/10.1056/NEJM199808203390806.
2. Otto M. 2013. Community-associated MRSA: what makes them special? Int J Med Microbiol 303:324–330. http://dx.doi.org/10.1016/j.ijmm.2013.02.007.
3. Thurlow LR, Joshi GS, Richardson AR. 2012. Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). FEMS Immunol Med Microbiol 65: 5–22. http://dx.doi.org/10.1111/j.1574-695X.2012.00937.x.
4. Chambers HF. 2001. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7:178–182. http://dx.doi.org/10.3201/eid0702.700178.
5. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy M-E, Etienne J. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978–984. http://dx.doi.org/10.3201/eid0908.030089.
6. Mediavilla JR, Chen L, Mathema B, Kreiswirth BN. 2012. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol 15:588–595. http://dx.doi.org/10.1016/j.mib.2012.08.003.
7. Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim G, Finelli L, Beekmann SE, Polgreen PM, Gorwitz R, Hageman J. 2009. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 53:358–365. http://dx.doi.org/10.1016/j.annemergmed.2008.04.027.
8. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. 2003. Pulsed-field gel electrophoresis typing of oxacillinresistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41:5113–5120. http://dx.doi.org/10.1128/JCM.41.11.5113-5120.2003.
9. Tenover FC, McDougal LK, Goering RV, Killgore G, Projan SJ, Patel JB, Dunman PM. 2006. Characterization of a strain of communityassociated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 44:108–118. http://dx.doi.org/10.1128/JCM.44.1.108-118.2006.
10. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731–739. http://dx.doi.org/10.1016/S0140-6736(06)68231-7.
11. Kennedy AD, Otto M, Braughton KR, Whitney AR, Chen L, Mathema B, Mediavilla JR, Byrne KA, Parkins LD, Tenover FC, Kreiswirth BN, Musser JM, DeLeo FR. 2008. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A 105:1327–1332. http://dx.doi.org/10.1073/pnas.0710217105.
12. Robinson DA, Enright MC. 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:3926–3934. http://dx.doi.org/10.1128/AAC.47.12.3926-3934.2003.
13. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y, Otto M. 2009. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 106:5883–5888. http://dx.doi.org/10.1073/pnas.0900743106.
14. Löffler B, Hussain M, Grundmeier M, Brück M, Holzinger D, Varga G, Roth J, Kahl BC, Proctor RA, Peters G. 2010. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6:e1000715. http://dx.doi.org/10.1371/journal.ppat.1000715.
15. Crémieux A-C, Dumitrescu O, Lina G, Vallee C, Côté J-F, Muffat-Joly M, Lilin T, Etienne J, Vandenesch F, Saleh-Mghir A. 2009. Panton-Valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One 4:e7204. http://dx.doi.org/10.1371/journal.pone.0007204.
16. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. 2006. Roles of 34 virulence genes in the evolution of hospital-and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 193:1495–1503. http://dx.doi.org/10.1086/503777.
17. Sabat AJ, Köck R, Akkerboom V, Hendrix R, Skov RL, Becker K, Friedrich AW. 2013. Novel organization of the arginine catabolic mobile element and staphylococcal cassette chromosome mec composite island and its horizontal transfer between distinct Staphylococcus aureus genotypes. Antimicrob Agents Chemother 57:5774–5777. http://dx.doi.org/10.1128/AAC.01321-13.
18. Bartels MD, Hansen LH, Boye K, Sørensen SJ, Westh H. 2011. An unexpected location of the arginine catabolic mobile element (ACME) in a USA300-related MRSA strain. PLoS One 6:e16193. http://dx.doi.org/10.1371/journal.pone.0016193.
19. Shore AC, Deasy EC, Slickers P, Brennan G, O’Connell B, Monecke S, Ehricht R, Coleman DC. 2011. Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillinresistant Staphylococcus aureus. Antimicrob Agents Chemother 55: 3765–3773. http://dx.doi.org/10.1128/AAC.00187-11.
20. Espedido BA, Steen JA, Barbagiannakos T, Mercer J, Paterson DL, Grimmond SM, Cooper MA, Gosbell IB, van Hal SJ, Jensen SO. 2012. Carriage of an Acme II variant may have contributed to methicillinresistant Staphylococcus aureus sequence type 239-like strain replacement in Liverpool Hospital, Sydney, Australia. Antimicrob Agents Chemother 56:3380–3383. http://dx.doi.org/10.1128/AAC.00013-12.
21. Goering RV, McDougal LK, Fosheim GE, Bonnstetter KK, Wolter DJ, Tenover FC. 2007. Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillinsusceptible Staphylococcus aureus isolates. J Clin Microbiol 45:1981–1984. http://dx.doi.org/10.1128/JCM.00273-07.
22. Thurlow LR, Joshi GS, Clark JR, Spontak JS, Neely CJ, Maile R, Richardson AR. 2013. Functional modularity of the arginine catabolic mobile element contributes to the success of USA300 methicillin-resistant Staphylococcus aureus. Cell Host Microbe 13:100–107. http://dx.doi.org/10.1016/j.chom.2012.11.012.
23. Planet PJ, LaRussa SJ, Dana A, Smith H, Xu A, Ryan C, Uhlemann A-C, Boundy S, Goldberg J, Narechania A, Kulkarni R, Ratner AJ, Geoghegan JA, Kolokotronis S-O, Prince A. 2013. Emergence of the epidemic methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speGmediated adaptations for survival on skin. mBio 4:e00889-13. http://dx.doi.org/10.1128/mBio.00889-13.
24. Nimmo GR. 2012. USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 18:725–734. http://dx.doi.org/10.1111/j.1469-0691.2012.03822.x.
25. Bartoloni A, Riccobono E, Magnelli D, Villagran AL, Di Maggio T, Mantella A, Sennati S, Revollo C, Strohmeyer M, Giani T, Pallecchi L, Rossolini GM. 2015. Methicillin-resistant Staphylococcus aureus in hospitalized patients from the Bolivian Chaco. Int J Infect Dis 30:156–160. http://dx.doi.org/10.1016/j.ijid.2014.12.006.
26. Reyes J, Rincón S, Díaz L, Panesso D, Contreras GA, Zurita J, Carrillo C, Rizzi A, Guzmán M, Adachi J, Chowdhury S, Murray BE, Arias CA. 2009. Dissemination of methicillin-resistant Staphylococcus aureus (MRSA), USA300 sequence type 8 lineage in Latin America. Clin Infect Dis 49:1861–1867. http://dx.doi.org/10.1086/648426.
27. Planet PJ, Diaz L, Kolokotronis S-O, Narechania A, Reyes J, Xing G, Rincon S, Smith H, Panesso D, Ryan C, Smith DP, Guzman M, Zurita J, Sebra R, Deikus G, Nolan RL, Tenover FC, Weinstock GM, Robinson DA, Arias CA. 2015. Parallel epidemics of community-associated methicillin-resistant Staphylococcus aureus USA300 infection in North and South America. J Infect Dis 212:1874–1882. http://dx.doi.org/10.1093/infdis/jiv320.
28. Otter JA, French GL. 2010. Molecular epidemiology of communityassociated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 10:227–239. http://dx.doi.org/10.1016/S1473-3099(10)70053-0.
29. Stegger M, Wirth T, Andersen PS, Skov RL, De Grassi A, Simões PM, Tristan A, Petersen A, Aziz M, Kiil K, Cirkovic´ I, Udo EE, del Campo R, Vuopio-Varkila J, Ahmad N, Tokajian S, Peters G, Schaumburg F, Olsson-Liljequist B, Givskov M, Driebe EE, Vigh HE, Shittu A, Ramdani-Bougessa N, Rasigade J-P, Price LB, Vandenesch F, Larsen AR, Laurent F. 2014. Origin and evolution of European communityacquired methicillin-resistant Staphylococcus aureus. mBio 5:e01044–01014. http://dx.doi.org/10.1128/mBio.01044-14.
30. Antri K, Rouzic N, Dauwalder O, Boubekri I, Bes M, Lina G, Vandenesch F, Tazir M, Ramdani-Bouguessa N, Etienne J. 2011. High prevalence of methicillin-resistant Staphylococcus aureus clone ST80-IV in hospital and community settings in Algiers. Clin Microbiol Infect 17: 526–532. http://dx.doi.org/10.1111/j.1469-0691.2010.03273.x.
31. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torné A, Witte W, Friedrich AW. 2010. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15:. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_19688.
32. Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, Friedrich AW, the European Staphylococcal Reference Laboratory Working Group. 2010. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecularepidemiological analysis. PLoS Med 7:e1000215. http://dx.doi.org/10.1371/journal.pmed.1000215.
33. Brauner J, Hallin M, Deplano A, De Mendonça R, Nonhoff C, De Ryck R, Roisin S, Struelens MJ, Denis O. 2013. Community-acquired methicillin-resistant Staphylococcus aureus clones circulating in Belgium from 2005 to 2009: changing epidemiology. Eur J Clin Microbiol Infect Dis 32:613–620. http://dx.doi.org/10.1007/s10096-012-1784-6.
34. Dodémont M. 2014. Epidémiologie moléculaire des souches de Staphylococcus aureus résistantes à la méticillin portant les gènes codant la leucocidine de Panton-Valentine en Belgique de 2010 à 2014. SympoStaph, Lyon, France.
35. Rolo J, Miragaia M, Turlej-Rogacka A, Empel J, Bouchami O, Faria NA, Tavares A, Hryniewicz W, Fluit AC, de Lencastre H, CONCORD Working Group. 2012. High genetic diversity among communityassociated Staphylococcus aureus in Europe: results from a multicenter study. PLoS One 7:e34768. http://dx.doi.org/10.1371/journal.pone.0034768.
36. Garnier F, Tristan A, François B, Etienne J, Delage-Corre M, Martin C, Liassine N, Wannet W, Denis F, Ploy M-C. 2006. Pneumonia and new methicillin-resistant Staphylococcus aureus clone. Emerg Infect Dis 12: 498–500. http://dx.doi.org/10.3201/eid1205.051040.
37. Blanco R, Tristan A, Ezpeleta G, Larsen AR, Bes M, Etienne J, Cisterna R, Laurent F. 2011. Molecular epidemiology of Panton-Valentine leukocidin-positive Staphylococcus aureus in Spain: emergence of the USA300 clone in an autochthonous population. J Clin Microbiol 49: 433–436. http://dx.doi.org/10.1128/JCM.02201-10.
38. Larsen A, Stegger M, Goering R, Sørum M, Skov R. 2007. Emergence and dissemination of the methicillin resistant Staphylococcus aureus USA300 clone in Denmark (2000–2005). Euro Surveill 12. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_682.
39. Kearns AM, Ganner M, Hill RLR, East C, McCormick Smith I, Ganner MA, Ellington MJ. 2007. O118 community-associated MRSA ST8-SCCmecIVa (USA-300): experience in England and Wales. Int J Antimicrob Agents 29(Suppl 2):S27. http://dx.doi.org/10.1016/S0924-8579(07)70087-0.
40. Baldan R, Tassan Din C, Semeraro G, Costa C, Cichero P, Scarpellini P, Moro M, Cirillo DM. 2009. Severe community onset infections in healthy individuals caused by community-acquired MRSA in an Italian teaching hospital, 2006–2008. J Hosp Infect 72:271–273. http://dx.doi.org/10.1016/j.jhin.2009.04.007.
41. Manzur A, Dominguez AM, Pujol M, González MP, Limon E, Hornero A, Martín R, Gudiol F, Ariza J. 2008. Community-acquired methicillinresistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect 14:377–380. http://dx.doi.org/10.1111/j.1469-0691.2007.01934.x.
42. Marimón JM, Villar M, García-Arenzana JM, de la Caba Ide L, Pérez-Trallero E. 2012. Molecular characterization of Staphylococcus aureus carrying the Panton-Valentine leucocidin genes in northern Spain. J Infect 64:47–53. http://dx.doi.org/10.1016/j.jinf.2011.10.010.
43. Armand-Lefevre L, Buke C, Ruppe E, Barbier F, Lolom I, Andremont A, Ruimy R, Lucet J-C. 2010. Secular trends and dynamics of hospital associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 16:1435–1441. http://dx.doi.org/10.1111/j.1469-0691.2009.03138.x.
44. Otter JA, Havill NL, Boyce JM, French GL. 2009. Comparison of community-associated methicillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004–2006: where is USA300 in the UK? Eur J Clin Microbiol Infect 28:835–839. http://dx.doi.org/10.1007/s10096-008-0698-9.
45. Ellington MJ, Perry C, Ganner M, Warner M, McCormick Smith I, Hill RL Shallcross L, Sabersheikh S, Holmes A, Cookson BD, Kearns AM, Kearns AM. 2009. Clinical and molecular epidemiology of ciprofloxacinsusceptible MRSA encoding PVL in England and Wales. Eur J Clin Microbiol Infect 28:1113–1121. http://dx.doi.org/10.1007/s10096-009-0757-x.
46. Huijsdens XW, Janssen M, Renders NH, Leenders A, van Wijk P, van Santen Verheuvel MG, van Driel JK, Morroy G. 2008. Methicillinresistant Staphylococcus aureus in a beauty salon, the Netherlands. Emerg Infect Dis 14:1797–1799. http://dx.doi.org/10.3201/eid1411.071297.
47. Baud O, Giron S, Aumeran C, Mouly D, Bardon G, Besson M, Delmas J, Coignard B, Tristan A, Vandenesch F, Illes G, Lesens O. 2014. First outbreak of community-acquired MRSA USA300 in France: failure to suppress prolonged MRSA carriage despite decontamination procedures. Eur J Clin Microbiol Infect 33:1757–1762. http://dx.doi.org/10.1007/s10096-014-2127-6.
48. Van der Mee-Marquet N, Poisson D-M, Lavigne J-P, Francia T, Tristan A, Vandenesch F, Quentin R, Bertrand X. 2015. The incidence of Staphylococcus aureus ST8-USA300amongFrench pediatric inpatients is rising. Eur J Clin Microbiol Infect 34:935–942. http://dx.doi.org/10.1007/s10096-014-2308-3.
49. Von Dach E, Diene SM, Fankhauser C, Schrenzel J, Harbarth S, François P. 13 October 2015. Comparative genomics of communityassociated methicillin-resistant Staphylococcus aureus shows the emergence of clone ST8-USA300 in Geneva, Switzerland. J Infect Dis. http://dx.doi.org/10.1093/infdis/jiv489.
50. Uhlemann A-C, Dordel J, Knox JR, Raven KE, Parkhill J, Holden MT, Peacock SJ, Lowy FD. 2014. Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci U S A 111:6738–6743. http://dx.doi.org/10.1073/pnas.1401006111.
51. Tewhey R, Cannavino CR, Leake JA, Bansal V, Topol EJ, Torkamani A, Bradley JS, Schork NJ. 2012. Genetic structure of community acquired methicillin-resistant Staphylococcus aureus USA300. BMC Genomics 13: 508. http://dx.doi.org/10.1186/1471-2164-13-508.
52. Kennedy AD, Porcella SF, Martens C, Whitney AR, Braughton KR, Chen L, Craig CT, Tenover FC, Kreiswirth BN, Musser JM, DeLeo FR. 2010. Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences. J Clin Microbiol 48: 4504–4511. http://dx.doi.org/10.1128/JCM.01050-10.
53. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7:214. http://dx.doi.org/10.1186/1471-2148-7-214.
54. Alam MT, Read TD, Petit RA, Boyle-Vavra S, Miller LG, Eells SJ, Daum RS, David MZ. 2015. Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing. mBio 6:e00054. http://dx.doi.org/10.1128/mBio.00054-15.
55. Nübel U, Roumagnac P, Feldkamp M, Song J-H, Ko KS, Huang Y-H, Coombs G, Ip M, Westh H, Skov R, Struelens MJ, Goering RV, Strommenger B, Weller A, Write W. 2010. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathog 6:e1000855. http://dx.doi.org/10.1371/journal.ppat.1000855.
56. Holden MT, Hsu L-Y, Kurt K, Weinert LA, Mather AE, Harris SR, Strommenger B, Layer F, Witte W, de Lencastre H, Skov R, Westh H, Zemlicková H, Coombs G, Kearns AM, Hill RL, Edgeworth J, Gould I, Gant V, Cooke J, Edwards GF, McAdam PR, Templeton KE, McCann A, Zhou Z, Castillo-Ramírez S, Feil EJ, Hudson LO, Enright MC, Balloux F, Aanensen DM, Spratt BG, Fitzgerald JR, Parkhill J, Achtman M, Bentley SD, Nübel U. 2013. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res 23:653–664. http://dx.doi.org/10.1101/gr.147710.112.
57. Duforet-Frebourg N, Bazin E, Blum MG. 2014. Genome scans for detecting footprints of local adaptation using a Bayesian factor model. Mol Biol Evol 31:2483–2495. http://dx.doi.org/10.1093/molbev/msu182.
58. Wirth T. 2015. Massive lineage replacements and cryptic outbreaks of Salmonella typhi in eastern and southern Africa. Nat Genet 47:565–567. http://dx.doi.org/10.1038/ng.3318.
59. Golubchik T, Batty EM, Miller RR, Farr H, Young BC, Larner-Svensson H, Fung R, Godwin H, Knox K, Votintseva A, Everitt RG, Street T, Cule M, Ip CL, Didelot X, Peto TE, Harding RM, Wilson DJ, Crook DW, Bowden R. 2013. Within-host evolution of Staphylococcus aureus during asymptomatic carriage. PLoS One 8:e61319. http://dx.doi.org/10.1371/journal.pone.0061319.
60. Price JR, Golubchik T, Cole K, Wilson DJ, Crook DW, Thwaites GE, Bowden R, Walker AS, Peto TEA, Paul J, Llewelyn MJ. 2014. Wholegenome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit. Clin Infect Dis 58:609–618. http://dx.doi.org/10.1093/cid/cit807.
61. Faria NA, Oliveira DC, Westh H, Monnet DL, Larsen AR, Skov R, de Lencastre H. 2005. Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection. J Clin Microbiol 43:1836–1842. http://dx.doi.org/10.1128/JCM.43.4.1836-1842.2005.
62. Herbert S, Ziebandt A-K, Ohlsen K, Schäfer T, Hecker M, Albrecht D, Novick R, Götz F. 2010. Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun 78:2877–2889. http://dx.doi.org/10.1128/IAI.00088-10.
63. Lee SM, Ender M, Adhikari R, Smith JM, Berger-Bächi B, Cook GM. 2007. Fitness cost of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus by way of continuous culture. Antimicrob Agents Chemother 51:1497–1499. http://dx.doi.org/10.1128/AAC.01239-06.
64. Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, Albrecht V, Moran GJ, EMERGEncy ID Net Study Group. 2011. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis 53: 144–149. http://dx.doi.org/10.1093/cid/cir308.
65. Klein E, Smith DL, Laxminarayan R. 2009. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999–2006. Emerg Infect Dis 15:1925–1930. http://dx.doi.org/10.3201/eid1512.081341.
66. Tenover FC, Goering RV. 2009. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 64:441–446. http://dx.doi.org/10.1093/jac/dkp241.
67. Ruppitsch W, Stoger A, Schmid D, Fretz R, Indra A, Allerberger F, Witte W. 2007. Occurrence of the USA300 community-acquired Staphylococcus aureus clone in Austria. Euro Surveill 12:. http://www.eurosurveillance.org/viewarticle.aspx?articleid_3294.
68. Morgan E. 2014. PVL+ MRSA on four continents: emergence and shifting genetic backgrounds in the literature, 1961–2013, Poster 168. International Symposium on Staphylococci and Staphylococcal Infections (ISSSI) 2014, Chicago, IL.
69. Krziwanek K, Luger C, Sammer B, Stumvoll S, Stammler M, Sagel U, Witte W, Mittermayer H. 2008. MRSA in Austria—an overview. Clin Microbiol Infect 14:250–259. http://dx.doi.org/10.1111/j.1469-0691.2007.01896.x.
70. Krziwanek K, Metz-Gercek S, Mittermayer H. 2011. Trends in the occurrence of MRSA strains in upper Austria from 2006 to 2009. Clin Microbiol Infect 17:920–923. http://dx.doi.org/10.1111/j.1469-0691.2010.03376.x.
71. Hsu L-Y, Harris SR, Chlebowicz MA, Lindsay JA, Koh T-H, Krishnan P, Tan T-Y, Hon P-Y, Grubb WB, Bentley SD, Parkhill J, Peacock SJ, Holden MT. 2015. Evolutionary dynamics of methicillin-resistant Staphylococcus aureus within a healthcare system. Genome Biol 16:81. http://dx.doi.org/10.1186/s13059-015-0643-z.
72. Chambers HF, DeLeo FR. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7:629–641. http://dx.doi.org/10.1038/nrmicro2200.
73. Knight GM, Budd EL, Whitney L, Thornley A, Al-Ghusein H, Planche T, Lindsay JA. 2012. Shift in dominant hospital-associated methicillinresistant Staphylococcus aureus (HA-MRSA) clones over time. J Antimicrob Chemother 67:2514–2522. http://dx.doi.org/10.1093/jac/dks245.
74. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S, Emerging Infections Program–Active Bacterial Core Surveillance MRSA, Surveillance Investigators. 2013. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 173:1970–1978. http://dx.doi.org/10.1001/jamainternmed.2013.10423.
75. Landrum ML, Neumann C, Cook C, Chukwuma U, Ellis MW, Hos-penthal DR, Murray CK. 2012. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005–2010. JAMA 308:50–59. http://dx.doi.org/10.1001/jama.2012.7139.
76. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Patel PR, Fridkin SK, Active bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections program. 2010. Health care of associated invasive MRSA infections, 2005–2008. JAMA 304:641–648. http://dx.doi.org/10.1001/jama.2010.1115.
77. Saïd-Salim B, Mathema B, Braughton K, Davis S, Sinsimer D, Eisner W, Likhoshvay Y, Deleo FR, Kreiswirth BN. 2005. Differential distribution and expression of Panton-Valentine leucocidin among communityacquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 43:3373–3379. http://dx.doi.org/10.1128/JCM.43.7.3373-3379.2005.
78. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O’Boyle C, Danila RN, Lynfield R. 2003. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290: 2976–2984. http://dx.doi.org/10.1001/jama.290.22.2976.
79. Monecke S, Jatzwauk L, Weber S, Slickers P, Ehricht R. 2008. DNA microarray-based genotyping of methicillin-resistant Staphylococcus aureus strains from eastern Saxony. Clin Microbiol Infect 14:534–545. http://dx.doi.org/10.1111/j.1469-0691.2008.01986.x.
80. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics Oxf Engl 25:1754–1760. http://dx.doi.org/10.1093/bioinformatics/btp324.
81. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. 2010. The genome analysis toolkit: a MapReduce framework for analyzing nextgeneration DNA sequencing data. Genome Res 20:1297–1303. http://dx.doi.org/10.1101/gr.107524.110.
82. Lechat P, Souche E, Moszer I. 2013. SynTView—an interactive multi-view genome browser for next-generation comparative microorganism genomics. BMC Bioinformatics 14:277. http://dx.doi.org/10.1186/1471-2105-14-277.
83. Milne I, Stephen G, Bayer M, Cock PJ, Pritchard L, Cardle L, Shaw PD, Marshall D. 2013. Using tablet for visual exploration of secondgeneration sequencing data. Brief Bioinform 14:193–202. http://dx.doi.org/10.1093/bib/bbs012.
84. Yarwood JM, McCormick JK, Paustian ML, Orwin PM, Kapur V, Schlievert PM. 2002. Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J Biol Chem 277:13138–13147. http://dx.doi.org/10.1074/jbc.M111661200.
85. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18:821–829. http://dx.doi.org/10.1101/gr.074492.107.
86. Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol 23:254–267. http://dx.doi.org/10.1093/molbev/msj030.
87. Bryant D, Moulton V. 2004. Neighbor-Net: an agglomerative method for the construction of phylogenetic networks. Mol Biol Evol 21:255–265. http://dx.doi.org/10.1093/molbev/msh018.
88. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. 2010. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59: 307–321. http://dx.doi.org/10.1093/sysbio/syq010.
89. Darriba D, Taboada GL, Doallo R, Posada D. 2012. JModelTest 2: More models, new heuristics and parallel computing. Nat Methods 9:772. http://dx.doi.org/10.1038/nmeth.2109.
90. Hasegawa M, Kishino H, Yano T. 1985. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 22:160–174. http://dx.doi.org/10.1007/BF02101694.
91. Drummond AJ, Rambaut A, Shapiro B, Pybus OG. 2005. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol Biol Evol 22:1185–1192. http://dx.doi.org/10.1093/molbev/msi103.